Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

Université de Montréal

$35,000.00

Multifunctional lipids based on a molecular switch for the improved delivery of nucleic acids

EF 2013-14

Résumé
Who could have envisaged it would be possible to use a gene as a drug 50 years ago, when the structure of DNA has just been discovered? Thanks to synergistic efforts of a whole scientific community, the concept has gone from bench to bedside, and two gene products are now available on the market. However, these new therapeutics are still in their first stages and require optimization. It is possible to improve their efficiency by the use of carefully engineered vectors, able to carry the genetic material through each of the biological barriers they need to cross. In particular, getting inside the cell is a major challenge, because these hydrophilic nucleic acids have to cross the lipid-rich plasmatic and/or endosomal membrane, before being degraded into lysosomes. Designing a lipidic vector able to destabilize the membrane upon a specific stimulus would facilitate nucleic acids to reach the cytoplasm of the targeted cell. This research program is focused on the design and evaluation of multifunctional lipids, bearing DNA binding affinity and pH-triggered membrane destabilization properties. The DNA binding affinity will be provided by variable cationic headgroups. The pH-sensitivity will be based on the use of previously developed molecular tweezer units, which have shown the suitable pH range for endosomal escape. This research program will process in three phases. In phase I, a library of 20 lipids will be synthesized and characterized. A selection process, based on their pH-triggered release and affinity for diverse nucleic acids, will be applied to select the best 6 candidates. The phase II will confirm the membrane-destabilizing properties and assess the transfection efficiency and cytotoxicity. The two best candidates will access to phase III, where the cytosolic delivery of nucleic acids will be imaged. Finally, a proof of concept in mice will evaluate the potential of these bioresponsive lipid nanoparticles to improve the efficiency of genetic material delivery in vivo.
Programme
Discovery Grants Program - Individual
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
408046-2012
Name nom
LeblondChain, Jeanne
Department département
Pharmacie, faculté de
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2012
Award amount
35000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
3705
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Bio-organic chemistry
Research subject fr
Chimie bio-organique
Partie
2
Nb partie
5
Application title
Multifunctional lipids based on a molecular switch for the improved delivery of nucleic acids
Keyword
NSERC
Application summary
Who could have envisaged it would be possible to use a gene as a drug 50 years ago, when the structure of DNA has just been discovered? Thanks to synergistic efforts of a whole scientific community, the concept has gone from bench to bedside, and two gene products are now available on the market. However, these new therapeutics are still in their first stages and require optimization. It is possible to improve their efficiency by the use of carefully engineered vectors, able to carry the genetic material through each of the biological barriers they need to cross. In particular, getting inside the cell is a major challenge, because these hydrophilic nucleic acids have to cross the lipid-rich plasmatic and/or endosomal membrane, before being degraded into lysosomes. Designing a lipidic vector able to destabilize the membrane upon a specific stimulus would facilitate nucleic acids to reach the cytoplasm of the targeted cell. This research program is focused on the design and evaluation of multifunctional lipids, bearing DNA binding affinity and pH-triggered membrane destabilization properties. The DNA binding affinity will be provided by variable cationic headgroups. The pH-sensitivity will be based on the use of previously developed molecular tweezer units, which have shown the suitable pH range for endosomal escape. This research program will process in three phases. In phase I, a library of 20 lipids will be synthesized and characterized. A selection process, based on their pH-triggered release and affinity for diverse nucleic acids, will be applied to select the best 6 candidates. The phase II will confirm the membrane-destabilizing properties and assess the transfection efficiency and cytotoxicity. The two best candidates will access to phase III, where the cytosolic delivery of nucleic acids will be imaged. Finally, a proof of concept in mice will evaluate the potential of these bioresponsive lipid nanoparticles to improve the efficiency of genetic material delivery in vivo.